NextCure Ownership | Who Owns NextCure?
NextCure Ownership Summary
NextCure is owned by 0.92% institutional investors, 20.17% insiders, and 78.92% retail investors. Blackrock is the largest institutional shareholder, holding 2.73% of NXTC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.19% of its assets in NextCure shares.
NXTC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | NextCure | 0.92% | 20.17% | 78.92% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 761.18K | 2.73% | $1.21M |
| Cardiff park advisors | 21.83K | 0.92% | $127.94K |
| Susquehanna group, llp | 48.19K | 0.17% | $37.15K |
| Millennium management | 42.52K | 0.15% | $32.78K |
| Bank of america corp /de/ | 5.37K | 0.02% | $8.54K |
| Citadel advisors | 1.40K | 0.01% | $2.23K |
| Rhumbline advisers | 703.00 | 0.00% | $1.12K |
| Royal bank of canada | 403.00 | 0.00% | $1.00K |
| Harbourvest partners | - | - | - |
| Barclays | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Cardiff park advisors | 21.83K | 0.01% | $127.94K |
| Blackrock | 761.18K | - | $1.21M |
| Renaissance | - | - | - |
| Engineers gate manager lp | - | - | - |
| Geode capital management | - | - | - |
| Harbourvest partners | - | - | - |
| Two sigma advisers, lp | - | - | - |
| Tower research capital llc (trc) | - | - | - |
| Barclays | - | - | - |
| Long focus capital management | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Susquehanna group, llp | 48.19K | - | 48.19K |
| Bank of america corp /de/ | 5.37K | - | 2.64K |
| Citadel advisors | 1.40K | - | 1.40K |
| Royal bank of canada | 403.00 | - | 403.00 |
| Rhumbline advisers | 703.00 | - | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sofinnova investments | - | - | -2.67M |
| Logos global management lp | - | - | -2.50M |
| Affinity asset advisors | - | - | -2.30M |
| Orbimed advisors | - | - | -1.14M |
| Citigroup | - | - | -1.03M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Susquehanna group, llp | 48.19K | - | 48.19K | $37.15K |
| Royal bank of canada | 403.00 | - | 403.00 | $1.00K |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -48.00 |
| Bnp paribas arbitrage, snc | -385.00 |
| Jpmorgan chase | -756.00 |
| Advisor group | -1.19K |
| Tower research capital llc (trc) | -1.53K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 1 | -96.55% | 21,833 | -99.79% | - | 0.07% | - | -100.00% | 1 | -88.89% |
| Jun 30, 2025 | 30 | -23.08% | 10,546,766 | -31.36% | 37 | 1.23% | 8 | -20.00% | 10 | 11.11% |
| Mar 31, 2025 | 39 | -15.22% | 15,365,612 | -4.18% | 54 | 1.67% | 10 | -28.57% | 9 | -30.77% |
| Dec 31, 2024 | 43 | -2.27% | 15,687,542 | -1.12% | 56 | 1.74% | 14 | 27.27% | 12 | 20.00% |
| Sep 30, 2024 | 44 | -10.20% | 15,865,008 | -0.90% | 56 | 1.72% | 11 | -42.11% | 10 | 11.11% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 613.83K | 2.19% | - |
| Vanguard Total Stock Mkt Idx Inv | 50.06K | 1.87% | -1.09K |
| Federated Hermes MDT Small Cap Growth IS | 315.18K | 1.12% | - |
| Federated Hermes MDT SCG Institutional | 315.18K | 1.12% | - |
| BlackRock Advantage Small Cap Core Instl | 169.79K | 0.61% | - |
| Delaware Healthcare I | 150.00K | 0.54% | - |
| Macquarie Healthcare I | 12.50K | 0.47% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 11.56K | 0.43% | -5.27K |
| Fidelity Extended Market Index | 10.28K | 0.38% | - |
| LUNIS Biotech Growth Opp Fd I a | 64.07K | 0.23% | -17.50K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q2 | - | - |
| 2023 Q1 | - | - |
| 2022 Q2 | - | - |
NXTC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools